Year: 2017
Type: dissertation
Abstract: Rheumatoid arthritis (RA) is a common autoimmune disease. Early RA is characterized by an initial break in immunological tolerance, the appearance of specific autoantibodies and a phase of “asymptomatic autoimmunity”. Finally, RA shifts into a state of active disease and manifests itself in autoantibody-mediated chronic synovitis which leads to cartilage and bone destruction. Apart from autoantibodies, the IL-23/Th17 axis has been identified as a major driving force during RA pathogenesis. The exact contribution of the IL-23/Th17 axis, however, has remained incompletely understood. Multiple “hits” through infectious agents and other environmental factors are suggested to be responsible for the transition from asymptomatic autoimmunity into active RA. However, checkpoints and mechanisms regulating this transition still remain obscure. In this work, we aimed to elucidate the role of the IL-23/Th17 axis during the pathogenesis of autoimmune arthritis. Therefore, we dissected the role of IL-23 during the initial break of tolerance and during the autoantibody mediated joint inflammation. Here we report, that the IL-23/Th17 axis does not directly contribute to antibody induced joint inflammation. Instead, IL-23 was found to be decisively involved in orchestrating the transition from asymptomatic autoimmunity into chronic autoimmune disease. Prior to the onset of experimental arthritis Th17 cells accumulated inside germinal centers of secondary lymphatic organs. There, IL-23 activated Th17 cells increased the pro-inflammatory activity of autoreactive antibodies by suppressing the expression of-galactoside 2,6 sialyltransferase (st6gal1) in developing plasma cells in a IL-21 and IL-22 dependent manner. Subsequently, autoantigen specific IgG glycosylation shifted towards a pro-inflammatory status which triggers the onset of arthritis. Similarly, plasmablasts from RA patients show a decreased st6gal1 activity compared to healthy control. IgG from these individuals showed corresponding changes in its glycosylation profile and inflammatory activity. The work presented in this thesis identifies a so far unrecognized mechanism by which Th17 cells unmask a preexisting breach in humoral tolerance and initiate the transition from a stage of asymptomatic autoimmunity into inflammatory autoimmune disease. The key findings of the work presented here have previously been published in Nature Immunology (Pfeifle et al. 20171).
Author: René Pfeifle
Institution: Friedrich-Alexander-Universität Erlangen-Nürnberg
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3133611943
